News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,494 Results
Type
Article (13836)
Company Profile (101)
Press Release (252557)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88088)
Career Advice (465)
Deals (15346)
Drug Delivery (67)
Drug Development (36611)
Employer Resources (49)
FDA (6301)
Job Trends (6205)
News (150287)
Policy (14049)
Tag
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23247)
ALS (39)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (46)
Approvals (6340)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (5)
Bankruptcy (149)
Best Places to Work (4371)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (656)
Cardiovascular disease (74)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (91)
Cervical cancer (4)
Clinical research (30983)
Collaboration (365)
Compensation (167)
Complete response letters (17)
COVID-19 (760)
CRISPR (23)
C-suite (134)
Cystic fibrosis (39)
Data (703)
Denatured (15)
Depression (10)
Diabetes (84)
Diagnostics (1327)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (70)
Drug shortages (12)
Duchenne muscular dystrophy (39)
Earnings (32375)
Editorial (14)
Employer branding (4)
Employer resources (43)
Events (37672)
Executive appointments (410)
FDA (6793)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (223)
Gene editing (41)
Generative AI (9)
Gene therapy (103)
GLP-1 (353)
Government (1307)
Grass and pollen (3)
Guidances (66)
Healthcare (3566)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (795)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (49)
Interviews (59)
IPO (5888)
IRA (29)
Job creations (2052)
Job search strategy (373)
Kidney cancer (6)
Labor market (14)
Layoffs (183)
Leadership (4)
Legal (3433)
Liver cancer (19)
Lung cancer (88)
Lymphoma (57)
Machine learning (4)
Management (16)
Manufacturing (173)
MASH (35)
Medical device (1278)
Medtech (1280)
Mergers & acquisitions (9677)
Metabolic disorders (271)
Multiple sclerosis (22)
NASH (14)
Neurodegenerative disease (27)
Neuropsychiatric disorders (8)
Neuroscience (592)
NextGen: Class of 2025 (1586)
Non-profit (595)
Now hiring (8)
Obesity (153)
Opinion (119)
Ovarian cancer (22)
Pain (58)
Pancreatic cancer (17)
Parkinson's disease (49)
Partnered (7)
Patents (130)
Patient recruitment (30)
Peanut (10)
People (29020)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (8064)
Phase II (13111)
Phase III (11761)
Pipeline (545)
Policy (74)
Postmarket research (1401)
Preclinical (3238)
Press Release (25)
Prostate cancer (49)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (175)
Real estate (2637)
Recruiting (17)
Regulatory (10159)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (39)
Series A (39)
Series B (15)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1631)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (39)
The Weekly (30)
Vaccines (160)
Venture capitalists (14)
Weight loss (101)
Women's health (8)
Worklife (4)
Date
Today (56)
Last 7 days (343)
Last 30 days (1062)
Last 365 days (11645)
2025 (4324)
2024 (12504)
2023 (14247)
2022 (19558)
2021 (20072)
2020 (19037)
2019 (14887)
2018 (11715)
2017 (13890)
2016 (13130)
2015 (15474)
2014 (12419)
2013 (10596)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (58)
Arkansas (3)
Asia (20177)
Australia (2618)
California (1861)
Canada (959)
China (257)
Colorado (72)
Connecticut (73)
Delaware (63)
Europe (39583)
Florida (361)
Georgia (40)
Idaho (9)
Illinois (206)
India (16)
Indiana (141)
Iowa (1)
Japan (101)
Kansas (60)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (275)
Massachusetts (1612)
Michigan (31)
Minnesota (100)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (815)
New Mexico (7)
New York (549)
North Carolina (409)
North Dakota (2)
Northern California (774)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (476)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (3)
Southern California (780)
Tennessee (36)
Texas (248)
United States (7754)
Utah (36)
Virginia (81)
Washington D.C. (32)
Washington State (127)
Wisconsin (19)
266,494 Results for "ironwood pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
May 7, 2025
·
19 min read
Press Releases
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
April 14, 2025
·
8 min read
Layoffs
Ironwood Chops Half of Staff as 2025 Guidance Disappoints
The layoffs will allow Ironwood to dedicate more resources to pushing its lead molecule apraglutide through a Phase III trial and a rolling NDA submission.
January 30, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
April 28, 2025
·
14 min read
Press Releases
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
February 21, 2025
·
1 min read
Press Releases
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
February 27, 2025
·
19 min read
Press Releases
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
April 23, 2025
·
12 min read
Business
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported its first quarter 2024 results and recent business performance.
May 9, 2024
·
34 min read
Genetown
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.
May 30, 2024
·
2 min read
1 of 26,650
Next
